Express-News: Rapamycin Holdings hires new CEO as its drug approaches human trials
June 25, 2017
Rapamycin Holdings has tapped a new CEO as it prepares to begin human trials for its prostate cancer drug eRapa later this year. Read the full story at the Express-News